This review guideline has been established to ensure that all manuscripts submitted to Convergence Hepatology are assessed rigorously, fairly, and transparently. Additionally, it emphasizes the journal's publication goals, which focus on the integration of imaging findings and clinical treatment of liver cancer or liver diseases, evaluation based on clinical progression, and convergence research involving various clinical medicine, basic science, and artificial intelligence.
Manuscripts should be evaluated according to the following criteria:
Reviewers should provide constructive, fair, and prompt feedback as follows:
The peer review process is summarized in the following steps and follows the flowchart:
Reviewers should provide clear recommendations with specific reasons:
For borderline cases, reviewers should explain concerns in detail and suggest additional data requests, reanalysis, or further explanation of major issues to ensure the editorial team can make an informed decision.
Reviewers should report any of the following ethical issues immediately:
When handling ethical issues, confidentiality must be strictly maintained to protect the rights of individuals involved in the review process.
Reviewers should complete their reviews within 2-3 weeks of receiving the manuscript. Extensions can be requested if needed.
The journal acknowledges the contributions of reviewers and provides the following rewards:
Authors may appeal editorial decisions by submitting a letter of appeal with specific reasons. Appeals are reviewed by an independent editor or reviewer to ensure fairness. The decision of the independent review is final and promptly communicated to the author.
These guidelines are reviewed annually and updated as necessary to reflect trends in scholarly publishing. Changes are announced through the journal's website.